E. Lunell
Impact in
- Physiology top 2%
- Smoking Behavior and Cessation
- Asthma and respiratory diseases
- Applied Psychology top 5%
- Behavioral Health and Interventions
Papers in
- Physiology 19
- Smoking Behavior and Cessation 14
- Asthma and respiratory diseases 9
-
- Respiratory and Cough-Related Research 12
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Co-authors
- Nina Schneider (3 shared papers)K.O. Fagerström (2 shared papers)Lars Molander (8 shared papers)Richard Olmstead (2 shared papers)C. G. A. Persson (6 shared papers)Karl‐Erik Andersson (6 shared papers)N Svedmyr (3 shared papers)Åke Westin (1 shared paper)
- Journals
- European Journal of Clinical Pharmacology (12 papers)Nicotine & Tobacco Research (4 papers)Clinical Pharmacology & Therapeutics (4 papers)Psychopharmacology (2 papers)Clinical Pharmacokinetics (2 papers)
- Partner nations
- SwedenUnited StatesNew Zealand
In The Last Decade
E. Lunell
31 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 109
- Physiology 862
- Applied Psychology 95
- Molecular Biology 583
- Pulmonary and Respiratory Medicine 273
- Pharmaceutical Science 49
Countries citing papers authored by E. Lunell
This map shows the geographic impact of E. Lunell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lunell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lunell more than expected).
Fields of papers citing papers by E. Lunell
This network shows the impact of papers produced by E. Lunell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lunell. The network helps show where E. Lunell may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Lunell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 147 | |
| 2 | 1997 | 116 | |
| 3 | 2001 | 116 | |
| 4 | 1996 | 111 | |
| 5 | 1995 | 78 | |
| 6 | 1982 | 73 | |
| 7 | 2020 | 70 | |
| 8 | 2000 | 68 | |
| 9 | 2005 | 59 | |
| 10 | 1999 | 43 | |
| 11 | 1983 | 39 | |
| 12 | 1996 | 35 | |
| 13 | 2011 | 34 | |
| 14 | 2001 | 33 | |
| 15 | 1996 | 31 | |
| 16 | Intravenous enprofylline in asthma patients. | 1984 | 31 |
| 17 | A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effect. | 1983 | 26 |
| 18 | 1988 | 25 | |
| 19 | 2000 | 24 | |
| 20 | 1996 | 22 |
About E. Lunell
E. Lunell is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Molecular Biology, Cardiology and Cardiovascular Medicine and Nutrition and Dietetics, having authored 31 papers that have together received 1.3k indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (14 papers), Respiratory and Cough-Related Research (12 papers), Asthma and respiratory diseases (9 papers), Nicotinic Acetylcholine Receptors Study (8 papers), Biochemical Analysis and Sensing Techniques (4 papers), Pharmaceutical studies and practices (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Physiology (862 citations), Applied Psychology (95 citations), Molecular Biology (583 citations), Pulmonary and Respiratory Medicine (273 citations) and Pharmaceutical Science (49 citations). E. Lunell has collaborated with scholars based in Sweden, United States and New Zealand. Frequent co-authors include Nina Schneider, K.O. Fagerström, Lars Molander, Richard Olmstead, C. G. A. Persson, Karl‐Erik Andersson, N Svedmyr, Åke Westin, Mikael Franzon and Karl‐Olov Fagerström. Their work appears in journals such as European Journal of Clinical Pharmacology, Nicotine & Tobacco Research, Clinical Pharmacology & Therapeutics, Psychopharmacology and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.